Key Developments: BSD Medical Corp (BSDM.W)
1.17USD
21 May 2013
$-0.01 (-0.85%)
$1.18
$1.17
$1.17
$1.17
200
1,101
$2.25
$0.79
Latest Key Developments (Source: Significant Developments)
BSD Medical Corp Closes $5 Million Registered Direct Offering of Common Stock and Warrants
BSD Medical Corp announced that the required closing of its previously announced $5.0 million registered direct offering of common stock and warrants occurred. Proceeds will be used for general working capital purposes, including to support BSD`s international expansion associated with its just announced master distribution agreement of its MicroThermX products in 100 countries, including Europe, Western Asia and Northern Africa and for the Company`s recently signed distribution agreement for its hyperthermia products in Taiwan. As previously disclosed, the Company sold 4,065,042 shares of its common stock at $1.23 per share to two institutional investors in the registered direct offering. In addition, warrants to purchase 3,048,782 shares of common stock in the aggregate were issued to the investors. The warrants are exercisable beginning six months and one day after April 12, 2013, expire 5 years after becoming exercisable, and have an exercise price of $1.65 per share. As previously disclosed, the transaction was required to close on or before April 12, 2013. Roth Capital Partners served as the placement agent for the offering. Full Article
BSD Medical Corp Announces Registered Direct Offering of Common Stock and Warrants in Aggregate Amount of $5 Million
BSD Medical Corp announced that it entered into a securities purchase agreement with two institutional investors for the sale of 4,065,042 shares of its common stock in a registered direct offering at $1.23 per share. In addition, warrants to purchase 3,048,782 shares of common stock in the aggregate will be issued to the investors. The warrants are exercisable beginning six months and one day after closing, expire five years after becoming exercisable, and have an exercise price of $1.65 per share. Gross proceeds of the offering, before deducting placement agent fees and other estimated offering expenses payable by BSD Medical Corporation, are expected to be approximately $5 million. The net proceeds from this offering will be used for general working capital purposes. The completion of the offering will occur on or before April 12, 2013. Roth Capital Partners served as the placement agent for the offering. Full Article
BSD Medical Corp Announces Exclusive Multi-Million Dollar Distribution Agreement With Terumo Europe NV
BSD Medical Corp announced that it has signed an exclusive, long-term, multi-million dollar distribution agreement with Terumo Europe NV, a wholly owned subsidiary of Terumo Corporation (Terumo), for the MicroThermX Microwave Ablation System (MicroThermX). Under the terms of the distribution agreement, Terumo Europe NV will have the exclusive right to market MicroThermX in 100 countries in Europe, Western Asia, and Northern Africa. Full Article
East Coast Academic Medical Center Purchases BSD Medical Corp's BSD-500 Hyperthermia System
BSD Medical Corp announced that a East Coast academic medical center (the Center) has purchased a BSD-500 Hyperthermia System (BSD-500). Terms of the transaction were not disclosed. Full Article
BSD Medical Corp Appoints William Barth As Chief Financial Officer
BSD Medical Corp announced that the appointment of William S. (Bill) Barth as Chief Financial Officer and Corporate Secretary. Mr. Barth commenced his employment with the Company on December 10, 2012, and will assume the duties of Chief Financial Officer and Corporate Secretary effective January 1, 2013, upon the departure of Dennis Gauger, current Chief Financial Officer and Corporate Secretary. Full Article
BSD Medical Corp Announces Resignation Of CFO-Form 8-K
BSD Medical Corp reported in its Form 8-K that on November 28, 2012, BSD Medical Corporation (Company) and Dennis P. Gauger entered into a written Separation Agreement and Release of All Claims pursuant to which Mr. Gauger resigned his position as the Chief Financial Officer (CFO) of the Company, effective at the close of business on December 31, 2012. Full Article
BSD Medical Corp Signs Exclusive Agreement With ADA Medikal For Distribution Of MicroThermX Microwave Ablation Line Of Products In Turkey
BSD Medical Corp announced that the Company has signed an exclusive agreement with ADA Medikal (ADA) for the sale and distribution of the MicroThermX Microwave Ablation (MicroThermX) line of products in Turkey. ADA is a medical specialty distributor in Turkey with offices in the metropolitan areas. Full Article
William Beaumont Hospital Purchases MicroThermX Microwave Ablation System From BSD Medical Corp
BSD Medical Corporation announced that the Company has sold a MicroThermX Microwave Ablation System (MicroThermX) to William Beaumont Hospital. William Beaumont is a three-hospital regional health system that is consistently recognized for its contributions to improving health care through research and technological innovations. Full Article
University of Miami Health Center Purchases MicroThermX Microwave Ablation System From BSD Medical Corporation
BSD Medical Corporation announced that the Company has sold a MicroThermX Microwave Ablation System (MicroThermX) to the University of Miami Hospital and Clinics (UMHC) to include the Sylvester Comprehensive Cancer Center (Sylvester) and the University of Miami Hospital. The MicroThermX will be used in both centers. Full Article
Cancer Treatment Centers of America Purchases Seventh Hyperthermia System from BSD Medical Corp
BSD Medical Corp announced that Cancer Treatment Centers of America (CTCA) at Southeastern Regional Medical Center has purchased a BSD-500 Hyperthermia System (BSD-500). CTCA Southeastern Regional Medical Center, located in the metropolitan Atlanta area, is a new 226,000-square-foot, all-digital hospital focused exclusively on treating cancer. Full Article
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
